Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
3,628
archived clinical trials in
Schizophrenia

Monotherapy Brexpiprazole (OPC-34712) Trial in the Treatment of Adults With Early-Episode Schizophrenia
Protocol 331-13-006: An Exploratory, Multicenter, Open-label, Monotherapy, Flexible-dose Brexpiprazole (OPC 34712) Trial in Adults With Early Episode Schizophrenia
Status: Enrolling
Updated:  2/26/2016
Clinical Research Facility
mi
from
Torrance, CA
Monotherapy Brexpiprazole (OPC-34712) Trial in the Treatment of Adults With Early-Episode Schizophrenia
Protocol 331-13-006: An Exploratory, Multicenter, Open-label, Monotherapy, Flexible-dose Brexpiprazole (OPC 34712) Trial in Adults With Early Episode Schizophrenia
Status: Enrolling
Updated: 2/26/2016
Clinical Research Facility
mi
from
Torrance, CA
Click here to add this to my saved trials
Monotherapy Brexpiprazole (OPC-34712) Trial in the Treatment of Adults With Early-Episode Schizophrenia
Protocol 331-13-006: An Exploratory, Multicenter, Open-label, Monotherapy, Flexible-dose Brexpiprazole (OPC 34712) Trial in Adults With Early Episode Schizophrenia
Status: Enrolling
Updated:  2/26/2016
Clinical Research Facility
mi
from
Fort Lauderdale, FL
Monotherapy Brexpiprazole (OPC-34712) Trial in the Treatment of Adults With Early-Episode Schizophrenia
Protocol 331-13-006: An Exploratory, Multicenter, Open-label, Monotherapy, Flexible-dose Brexpiprazole (OPC 34712) Trial in Adults With Early Episode Schizophrenia
Status: Enrolling
Updated: 2/26/2016
Clinical Research Facility
mi
from
Fort Lauderdale, FL
Click here to add this to my saved trials
Monotherapy Brexpiprazole (OPC-34712) Trial in the Treatment of Adults With Early-Episode Schizophrenia
Protocol 331-13-006: An Exploratory, Multicenter, Open-label, Monotherapy, Flexible-dose Brexpiprazole (OPC 34712) Trial in Adults With Early Episode Schizophrenia
Status: Enrolling
Updated:  2/26/2016
Clinical Research Facility
mi
from
Atlanta, GA
Monotherapy Brexpiprazole (OPC-34712) Trial in the Treatment of Adults With Early-Episode Schizophrenia
Protocol 331-13-006: An Exploratory, Multicenter, Open-label, Monotherapy, Flexible-dose Brexpiprazole (OPC 34712) Trial in Adults With Early Episode Schizophrenia
Status: Enrolling
Updated: 2/26/2016
Clinical Research Facility
mi
from
Atlanta, GA
Click here to add this to my saved trials
Monotherapy Brexpiprazole (OPC-34712) Trial in the Treatment of Adults With Early-Episode Schizophrenia
Protocol 331-13-006: An Exploratory, Multicenter, Open-label, Monotherapy, Flexible-dose Brexpiprazole (OPC 34712) Trial in Adults With Early Episode Schizophrenia
Status: Enrolling
Updated:  2/26/2016
Clinical Research Facility
mi
from
Hoffman Estates, IL
Monotherapy Brexpiprazole (OPC-34712) Trial in the Treatment of Adults With Early-Episode Schizophrenia
Protocol 331-13-006: An Exploratory, Multicenter, Open-label, Monotherapy, Flexible-dose Brexpiprazole (OPC 34712) Trial in Adults With Early Episode Schizophrenia
Status: Enrolling
Updated: 2/26/2016
Clinical Research Facility
mi
from
Hoffman Estates, IL
Click here to add this to my saved trials
Monotherapy Brexpiprazole (OPC-34712) Trial in the Treatment of Adults With Early-Episode Schizophrenia
Protocol 331-13-006: An Exploratory, Multicenter, Open-label, Monotherapy, Flexible-dose Brexpiprazole (OPC 34712) Trial in Adults With Early Episode Schizophrenia
Status: Enrolling
Updated:  2/26/2016
Clinical Research Facility
mi
from
Lake Charles, LA
Monotherapy Brexpiprazole (OPC-34712) Trial in the Treatment of Adults With Early-Episode Schizophrenia
Protocol 331-13-006: An Exploratory, Multicenter, Open-label, Monotherapy, Flexible-dose Brexpiprazole (OPC 34712) Trial in Adults With Early Episode Schizophrenia
Status: Enrolling
Updated: 2/26/2016
Clinical Research Facility
mi
from
Lake Charles, LA
Click here to add this to my saved trials
Monotherapy Brexpiprazole (OPC-34712) Trial in the Treatment of Adults With Early-Episode Schizophrenia
Protocol 331-13-006: An Exploratory, Multicenter, Open-label, Monotherapy, Flexible-dose Brexpiprazole (OPC 34712) Trial in Adults With Early Episode Schizophrenia
Status: Enrolling
Updated:  2/26/2016
Clinical Research Facility
mi
from
Rochester, NY
Monotherapy Brexpiprazole (OPC-34712) Trial in the Treatment of Adults With Early-Episode Schizophrenia
Protocol 331-13-006: An Exploratory, Multicenter, Open-label, Monotherapy, Flexible-dose Brexpiprazole (OPC 34712) Trial in Adults With Early Episode Schizophrenia
Status: Enrolling
Updated: 2/26/2016
Clinical Research Facility
mi
from
Rochester, NY
Click here to add this to my saved trials
Monotherapy Brexpiprazole (OPC-34712) Trial in the Treatment of Adults With Early-Episode Schizophrenia
Protocol 331-13-006: An Exploratory, Multicenter, Open-label, Monotherapy, Flexible-dose Brexpiprazole (OPC 34712) Trial in Adults With Early Episode Schizophrenia
Status: Enrolling
Updated:  2/26/2016
Clinical Research Facility
mi
from
Philadelphia, PA
Monotherapy Brexpiprazole (OPC-34712) Trial in the Treatment of Adults With Early-Episode Schizophrenia
Protocol 331-13-006: An Exploratory, Multicenter, Open-label, Monotherapy, Flexible-dose Brexpiprazole (OPC 34712) Trial in Adults With Early Episode Schizophrenia
Status: Enrolling
Updated: 2/26/2016
Clinical Research Facility
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Monotherapy Brexpiprazole (OPC-34712) Trial in the Treatment of Adults With Early-Episode Schizophrenia
Protocol 331-13-006: An Exploratory, Multicenter, Open-label, Monotherapy, Flexible-dose Brexpiprazole (OPC 34712) Trial in Adults With Early Episode Schizophrenia
Status: Enrolling
Updated:  2/26/2016
Clinical Research Facility
mi
from
Memphis, TN
Monotherapy Brexpiprazole (OPC-34712) Trial in the Treatment of Adults With Early-Episode Schizophrenia
Protocol 331-13-006: An Exploratory, Multicenter, Open-label, Monotherapy, Flexible-dose Brexpiprazole (OPC 34712) Trial in Adults With Early Episode Schizophrenia
Status: Enrolling
Updated: 2/26/2016
Clinical Research Facility
mi
from
Memphis, TN
Click here to add this to my saved trials
Monotherapy Brexpiprazole (OPC-34712) Trial in the Treatment of Adults With Early-Episode Schizophrenia
Protocol 331-13-006: An Exploratory, Multicenter, Open-label, Monotherapy, Flexible-dose Brexpiprazole (OPC 34712) Trial in Adults With Early Episode Schizophrenia
Status: Enrolling
Updated:  2/26/2016
Clinical Research Facility
mi
from
Dallas, TX
Monotherapy Brexpiprazole (OPC-34712) Trial in the Treatment of Adults With Early-Episode Schizophrenia
Protocol 331-13-006: An Exploratory, Multicenter, Open-label, Monotherapy, Flexible-dose Brexpiprazole (OPC 34712) Trial in Adults With Early Episode Schizophrenia
Status: Enrolling
Updated: 2/26/2016
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
Monotherapy Brexpiprazole (OPC-34712) Trial in the Treatment of Adults With Early-Episode Schizophrenia
Protocol 331-13-006: An Exploratory, Multicenter, Open-label, Monotherapy, Flexible-dose Brexpiprazole (OPC 34712) Trial in Adults With Early Episode Schizophrenia
Status: Enrolling
Updated:  2/26/2016
Clinical Research Facility
mi
from
Dallas, TX
Monotherapy Brexpiprazole (OPC-34712) Trial in the Treatment of Adults With Early-Episode Schizophrenia
Protocol 331-13-006: An Exploratory, Multicenter, Open-label, Monotherapy, Flexible-dose Brexpiprazole (OPC 34712) Trial in Adults With Early Episode Schizophrenia
Status: Enrolling
Updated: 2/26/2016
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
Monotherapy Brexpiprazole (OPC-34712) Trial in the Treatment of Adults With Early-Episode Schizophrenia
Protocol 331-13-006: An Exploratory, Multicenter, Open-label, Monotherapy, Flexible-dose Brexpiprazole (OPC 34712) Trial in Adults With Early Episode Schizophrenia
Status: Enrolling
Updated:  2/26/2016
Clinical Research Facility
mi
from
Houston, TX
Monotherapy Brexpiprazole (OPC-34712) Trial in the Treatment of Adults With Early-Episode Schizophrenia
Protocol 331-13-006: An Exploratory, Multicenter, Open-label, Monotherapy, Flexible-dose Brexpiprazole (OPC 34712) Trial in Adults With Early Episode Schizophrenia
Status: Enrolling
Updated: 2/26/2016
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
Multiple Ascending Dose Study on Safety, Tolerability, and Pharmacokinetics of AMG 581 in Healthy Subjects or Subjects With Schizophrenia or Schizoaffective
A Phase I, Randomized, Placebo-controlled, Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of AMG 581 in Healthy Subjects or Subjects With Schizophrenia or Schizoaffective Disorder on Antipsychotic Medication
Status: Enrolling
Updated:  3/4/2016
Clinical Research Facility
mi
from
Glendale, CA
Multiple Ascending Dose Study on Safety, Tolerability, and Pharmacokinetics of AMG 581 in Healthy Subjects or Subjects With Schizophrenia or Schizoaffective
A Phase I, Randomized, Placebo-controlled, Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of AMG 581 in Healthy Subjects or Subjects With Schizophrenia or Schizoaffective Disorder on Antipsychotic Medication
Status: Enrolling
Updated: 3/4/2016
Clinical Research Facility
mi
from
Glendale, CA
Click here to add this to my saved trials
Multiple Ascending Dose Study on Safety, Tolerability, and Pharmacokinetics of AMG 581 in Healthy Subjects or Subjects With Schizophrenia or Schizoaffective
A Phase I, Randomized, Placebo-controlled, Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of AMG 581 in Healthy Subjects or Subjects With Schizophrenia or Schizoaffective Disorder on Antipsychotic Medication
Status: Enrolling
Updated:  3/4/2016
Parexel
mi
from
Glendale, CA
Multiple Ascending Dose Study on Safety, Tolerability, and Pharmacokinetics of AMG 581 in Healthy Subjects or Subjects With Schizophrenia or Schizoaffective
A Phase I, Randomized, Placebo-controlled, Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of AMG 581 in Healthy Subjects or Subjects With Schizophrenia or Schizoaffective Disorder on Antipsychotic Medication
Status: Enrolling
Updated: 3/4/2016
Parexel
mi
from
Glendale, CA
Click here to add this to my saved trials
Decreasing Risk of Coronary Artery Disease in Schizophrenia by Omega-3 Fatty Acid Supplementation
CAD Risk in Schizophrenia: Effect of Omega-3 Fatty Acid Supplementation
Status: Enrolling
Updated:  3/7/2016
VA Pittsburgh Healthcare System (University Drive)
mi
from
Pittsburgh, PA
Decreasing Risk of Coronary Artery Disease in Schizophrenia by Omega-3 Fatty Acid Supplementation
CAD Risk in Schizophrenia: Effect of Omega-3 Fatty Acid Supplementation
Status: Enrolling
Updated: 3/7/2016
VA Pittsburgh Healthcare System (University Drive)
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
PEARL Schizophrenia Maintenance
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study Of Lurasidone For The Maintenance Treatment Of Subjects With Schizophrenia
Status: Enrolling
Updated:  3/10/2016
Woodland Research Northwest
mi
from
Springdale, AZ
PEARL Schizophrenia Maintenance
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study Of Lurasidone For The Maintenance Treatment Of Subjects With Schizophrenia
Status: Enrolling
Updated: 3/10/2016
Woodland Research Northwest
mi
from
Springdale, AZ
Click here to add this to my saved trials
PEARL Schizophrenia Maintenance
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study Of Lurasidone For The Maintenance Treatment Of Subjects With Schizophrenia
Status: Enrolling
Updated:  3/10/2016
K&S Professional Research
mi
from
Little Rock, AR
PEARL Schizophrenia Maintenance
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study Of Lurasidone For The Maintenance Treatment Of Subjects With Schizophrenia
Status: Enrolling
Updated: 3/10/2016
K&S Professional Research
mi
from
Little Rock, AR
Click here to add this to my saved trials
PEARL Schizophrenia Maintenance
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study Of Lurasidone For The Maintenance Treatment Of Subjects With Schizophrenia
Status: Enrolling
Updated:  3/10/2016
Woodland International Research Group, Inc.
mi
from
Little Rock, AR
PEARL Schizophrenia Maintenance
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study Of Lurasidone For The Maintenance Treatment Of Subjects With Schizophrenia
Status: Enrolling
Updated: 3/10/2016
Woodland International Research Group, Inc.
mi
from
Little Rock, AR
Click here to add this to my saved trials
PEARL Schizophrenia Maintenance
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study Of Lurasidone For The Maintenance Treatment Of Subjects With Schizophrenia
Status: Enrolling
Updated:  3/10/2016
Comprehensive Clinical Development Inc.
mi
from
Cerritos, CA
PEARL Schizophrenia Maintenance
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study Of Lurasidone For The Maintenance Treatment Of Subjects With Schizophrenia
Status: Enrolling
Updated: 3/10/2016
Comprehensive Clinical Development Inc.
mi
from
Cerritos, CA
Click here to add this to my saved trials
PEARL Schizophrenia Maintenance
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study Of Lurasidone For The Maintenance Treatment Of Subjects With Schizophrenia
Status: Enrolling
Updated:  3/10/2016
Diligent Clinical Trials
mi
from
Downey, CA
PEARL Schizophrenia Maintenance
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study Of Lurasidone For The Maintenance Treatment Of Subjects With Schizophrenia
Status: Enrolling
Updated: 3/10/2016
Diligent Clinical Trials
mi
from
Downey, CA
Click here to add this to my saved trials
PEARL Schizophrenia Maintenance
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study Of Lurasidone For The Maintenance Treatment Of Subjects With Schizophrenia
Status: Enrolling
Updated:  3/10/2016
Synergy Escondido
mi
from
Escondido, CA
PEARL Schizophrenia Maintenance
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study Of Lurasidone For The Maintenance Treatment Of Subjects With Schizophrenia
Status: Enrolling
Updated: 3/10/2016
Synergy Escondido
mi
from
Escondido, CA
Click here to add this to my saved trials
PEARL Schizophrenia Maintenance
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study Of Lurasidone For The Maintenance Treatment Of Subjects With Schizophrenia
Status: Enrolling
Updated:  3/10/2016
Axis Clinical Trials
mi
from
Los Angeles, CA
PEARL Schizophrenia Maintenance
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study Of Lurasidone For The Maintenance Treatment Of Subjects With Schizophrenia
Status: Enrolling
Updated: 3/10/2016
Axis Clinical Trials
mi
from
Los Angeles, CA
Click here to add this to my saved trials
PEARL Schizophrenia Maintenance
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study Of Lurasidone For The Maintenance Treatment Of Subjects With Schizophrenia
Status: Enrolling
Updated:  3/10/2016
Synergy Clinical Research Center
mi
from
National City, CA
PEARL Schizophrenia Maintenance
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study Of Lurasidone For The Maintenance Treatment Of Subjects With Schizophrenia
Status: Enrolling
Updated: 3/10/2016
Synergy Clinical Research Center
mi
from
National City, CA
Click here to add this to my saved trials
PEARL Schizophrenia Maintenance
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study Of Lurasidone For The Maintenance Treatment Of Subjects With Schizophrenia
Status: Enrolling
Updated:  3/10/2016
Excell Clinical Trials
mi
from
Oceanside, CA
PEARL Schizophrenia Maintenance
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study Of Lurasidone For The Maintenance Treatment Of Subjects With Schizophrenia
Status: Enrolling
Updated: 3/10/2016
Excell Clinical Trials
mi
from
Oceanside, CA
Click here to add this to my saved trials
PEARL Schizophrenia Maintenance
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study Of Lurasidone For The Maintenance Treatment Of Subjects With Schizophrenia
Status: Enrolling
Updated:  3/10/2016
CNRI - Los Angeles LLC,8309 Telegraph Road
mi
from
Pico Rivera, CA
PEARL Schizophrenia Maintenance
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study Of Lurasidone For The Maintenance Treatment Of Subjects With Schizophrenia
Status: Enrolling
Updated: 3/10/2016
CNRI - Los Angeles LLC,8309 Telegraph Road
mi
from
Pico Rivera, CA
Click here to add this to my saved trials
PEARL Schizophrenia Maintenance
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study Of Lurasidone For The Maintenance Treatment Of Subjects With Schizophrenia
Status: Enrolling
Updated:  3/10/2016
California Neuropsychopharmacology Clinical Research Instit
mi
from
San Diego, CA
PEARL Schizophrenia Maintenance
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study Of Lurasidone For The Maintenance Treatment Of Subjects With Schizophrenia
Status: Enrolling
Updated: 3/10/2016
California Neuropsychopharmacology Clinical Research Instit
mi
from
San Diego, CA
Click here to add this to my saved trials
PEARL Schizophrenia Maintenance
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study Of Lurasidone For The Maintenance Treatment Of Subjects With Schizophrenia
Status: Enrolling
Updated:  3/10/2016
Neuropsychiatric Research Center of Orange County
mi
from
Santa Ana, CA
PEARL Schizophrenia Maintenance
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study Of Lurasidone For The Maintenance Treatment Of Subjects With Schizophrenia
Status: Enrolling
Updated: 3/10/2016
Neuropsychiatric Research Center of Orange County
mi
from
Santa Ana, CA
Click here to add this to my saved trials
PEARL Schizophrenia Maintenance
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study Of Lurasidone For The Maintenance Treatment Of Subjects With Schizophrenia
Status: Enrolling
Updated:  3/10/2016
Collaborative Neuroscience Network, INC
mi
from
Torrance, CA
PEARL Schizophrenia Maintenance
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study Of Lurasidone For The Maintenance Treatment Of Subjects With Schizophrenia
Status: Enrolling
Updated: 3/10/2016
Collaborative Neuroscience Network, INC
mi
from
Torrance, CA
Click here to add this to my saved trials
PEARL Schizophrenia Maintenance
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study Of Lurasidone For The Maintenance Treatment Of Subjects With Schizophrenia
Status: Enrolling
Updated:  3/10/2016
Florida Clinical Research Center, LLC
mi
from
Bradenton, FL
PEARL Schizophrenia Maintenance
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study Of Lurasidone For The Maintenance Treatment Of Subjects With Schizophrenia
Status: Enrolling
Updated: 3/10/2016
Florida Clinical Research Center, LLC
mi
from
Bradenton, FL
Click here to add this to my saved trials
PEARL Schizophrenia Maintenance
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study Of Lurasidone For The Maintenance Treatment Of Subjects With Schizophrenia
Status: Enrolling
Updated:  3/10/2016
Galiz Research
mi
from
Miami Springs, FL
PEARL Schizophrenia Maintenance
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study Of Lurasidone For The Maintenance Treatment Of Subjects With Schizophrenia
Status: Enrolling
Updated: 3/10/2016
Galiz Research
mi
from
Miami Springs, FL
Click here to add this to my saved trials
PEARL Schizophrenia Maintenance
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study Of Lurasidone For The Maintenance Treatment Of Subjects With Schizophrenia
Status: Enrolling
Updated:  3/10/2016
Comprehensive NeuroScience, Inc.
mi
from
Atlanta, GA
PEARL Schizophrenia Maintenance
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study Of Lurasidone For The Maintenance Treatment Of Subjects With Schizophrenia
Status: Enrolling
Updated: 3/10/2016
Comprehensive NeuroScience, Inc.
mi
from
Atlanta, GA
Click here to add this to my saved trials
PEARL Schizophrenia Maintenance
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study Of Lurasidone For The Maintenance Treatment Of Subjects With Schizophrenia
Status: Enrolling
Updated:  3/10/2016
Atlanta Center for Medical Research
mi
from
Atlanta, GA
PEARL Schizophrenia Maintenance
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study Of Lurasidone For The Maintenance Treatment Of Subjects With Schizophrenia
Status: Enrolling
Updated: 3/10/2016
Atlanta Center for Medical Research
mi
from
Atlanta, GA
Click here to add this to my saved trials
PEARL Schizophrenia Maintenance
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study Of Lurasidone For The Maintenance Treatment Of Subjects With Schizophrenia
Status: Enrolling
Updated:  3/10/2016
Lake Charles Clinical Trials LLC
mi
from
Lake Charles, LA
PEARL Schizophrenia Maintenance
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study Of Lurasidone For The Maintenance Treatment Of Subjects With Schizophrenia
Status: Enrolling
Updated: 3/10/2016
Lake Charles Clinical Trials LLC
mi
from
Lake Charles, LA
Click here to add this to my saved trials
PEARL Schizophrenia Maintenance
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study Of Lurasidone For The Maintenance Treatment Of Subjects With Schizophrenia
Status: Enrolling
Updated:  3/10/2016
Lousiana Clinical Research, LLC
mi
from
Shreveport, LA
PEARL Schizophrenia Maintenance
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study Of Lurasidone For The Maintenance Treatment Of Subjects With Schizophrenia
Status: Enrolling
Updated: 3/10/2016
Lousiana Clinical Research, LLC
mi
from
Shreveport, LA
Click here to add this to my saved trials
PEARL Schizophrenia Maintenance
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study Of Lurasidone For The Maintenance Treatment Of Subjects With Schizophrenia
Status: Enrolling
Updated:  3/10/2016
CBH Health LLC
mi
from
Rockville, MD
PEARL Schizophrenia Maintenance
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study Of Lurasidone For The Maintenance Treatment Of Subjects With Schizophrenia
Status: Enrolling
Updated: 3/10/2016
CBH Health LLC
mi
from
Rockville, MD
Click here to add this to my saved trials
PEARL Schizophrenia Maintenance
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study Of Lurasidone For The Maintenance Treatment Of Subjects With Schizophrenia
Status: Enrolling
Updated:  3/10/2016
Psych Care Consultants Research
mi
from
St. Louis, MO
PEARL Schizophrenia Maintenance
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study Of Lurasidone For The Maintenance Treatment Of Subjects With Schizophrenia
Status: Enrolling
Updated: 3/10/2016
Psych Care Consultants Research
mi
from
St. Louis, MO
Click here to add this to my saved trials
PEARL Schizophrenia Maintenance
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study Of Lurasidone For The Maintenance Treatment Of Subjects With Schizophrenia
Status: Enrolling
Updated:  3/10/2016
Center for Psychiatry and Behavioral Medicine, Inc.
mi
from
Las Vegas, NV
PEARL Schizophrenia Maintenance
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study Of Lurasidone For The Maintenance Treatment Of Subjects With Schizophrenia
Status: Enrolling
Updated: 3/10/2016
Center for Psychiatry and Behavioral Medicine, Inc.
mi
from
Las Vegas, NV
Click here to add this to my saved trials
PEARL Schizophrenia Maintenance
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study Of Lurasidone For The Maintenance Treatment Of Subjects With Schizophrenia
Status: Enrolling
Updated:  3/10/2016
Horne Research
mi
from
Las Vegas, NV
PEARL Schizophrenia Maintenance
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study Of Lurasidone For The Maintenance Treatment Of Subjects With Schizophrenia
Status: Enrolling
Updated: 3/10/2016
Horne Research
mi
from
Las Vegas, NV
Click here to add this to my saved trials
PEARL Schizophrenia Maintenance
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study Of Lurasidone For The Maintenance Treatment Of Subjects With Schizophrenia
Status: Enrolling
Updated:  3/10/2016
CRI Worldwide, LLC
mi
from
Willingboro, NJ
PEARL Schizophrenia Maintenance
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study Of Lurasidone For The Maintenance Treatment Of Subjects With Schizophrenia
Status: Enrolling
Updated: 3/10/2016
CRI Worldwide, LLC
mi
from
Willingboro, NJ
Click here to add this to my saved trials
PEARL Schizophrenia Maintenance
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study Of Lurasidone For The Maintenance Treatment Of Subjects With Schizophrenia
Status: Enrolling
Updated:  3/10/2016
University of New York, Dept. of Psychiatry
mi
from
Buffalo, NY
PEARL Schizophrenia Maintenance
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study Of Lurasidone For The Maintenance Treatment Of Subjects With Schizophrenia
Status: Enrolling
Updated: 3/10/2016
University of New York, Dept. of Psychiatry
mi
from
Buffalo, NY
Click here to add this to my saved trials
PEARL Schizophrenia Maintenance
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study Of Lurasidone For The Maintenance Treatment Of Subjects With Schizophrenia
Status: Enrolling
Updated:  3/10/2016
Neurobehavioral Research, Inc.
mi
from
Cedarhurst, NY
PEARL Schizophrenia Maintenance
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study Of Lurasidone For The Maintenance Treatment Of Subjects With Schizophrenia
Status: Enrolling
Updated: 3/10/2016
Neurobehavioral Research, Inc.
mi
from
Cedarhurst, NY
Click here to add this to my saved trials
PEARL Schizophrenia Maintenance
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study Of Lurasidone For The Maintenance Treatment Of Subjects With Schizophrenia
Status: Enrolling
Updated:  3/10/2016
Comprehensive Clinical Development, Inc
mi
from
Fresh Meadows, NY
PEARL Schizophrenia Maintenance
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study Of Lurasidone For The Maintenance Treatment Of Subjects With Schizophrenia
Status: Enrolling
Updated: 3/10/2016
Comprehensive Clinical Development, Inc
mi
from
Fresh Meadows, NY
Click here to add this to my saved trials
PEARL Schizophrenia Maintenance
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study Of Lurasidone For The Maintenance Treatment Of Subjects With Schizophrenia
Status: Enrolling
Updated:  3/10/2016
Finger Lakes Clinical Research
mi
from
Rochester, NY
PEARL Schizophrenia Maintenance
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study Of Lurasidone For The Maintenance Treatment Of Subjects With Schizophrenia
Status: Enrolling
Updated: 3/10/2016
Finger Lakes Clinical Research
mi
from
Rochester, NY
Click here to add this to my saved trials
PEARL Schizophrenia Maintenance
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study Of Lurasidone For The Maintenance Treatment Of Subjects With Schizophrenia
Status: Enrolling
Updated:  3/10/2016
Behavioral Medical Research of Staten Island
mi
from
Staten Island, NY
PEARL Schizophrenia Maintenance
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study Of Lurasidone For The Maintenance Treatment Of Subjects With Schizophrenia
Status: Enrolling
Updated: 3/10/2016
Behavioral Medical Research of Staten Island
mi
from
Staten Island, NY
Click here to add this to my saved trials
PEARL Schizophrenia Maintenance
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study Of Lurasidone For The Maintenance Treatment Of Subjects With Schizophrenia
Status: Enrolling
Updated:  3/10/2016
Oklahoma Clinical Research
mi
from
Oklahoma City, OK
PEARL Schizophrenia Maintenance
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study Of Lurasidone For The Maintenance Treatment Of Subjects With Schizophrenia
Status: Enrolling
Updated: 3/10/2016
Oklahoma Clinical Research
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
PEARL Schizophrenia Maintenance
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study Of Lurasidone For The Maintenance Treatment Of Subjects With Schizophrenia
Status: Enrolling
Updated:  3/10/2016
Cutting Edge Research Group
mi
from
Oklahoma City, OK
PEARL Schizophrenia Maintenance
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study Of Lurasidone For The Maintenance Treatment Of Subjects With Schizophrenia
Status: Enrolling
Updated: 3/10/2016
Cutting Edge Research Group
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
PEARL Schizophrenia Maintenance
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study Of Lurasidone For The Maintenance Treatment Of Subjects With Schizophrenia
Status: Enrolling
Updated:  3/10/2016
CRI Worldwide - Kirkbride
mi
from
Philadelphia, PA
PEARL Schizophrenia Maintenance
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study Of Lurasidone For The Maintenance Treatment Of Subjects With Schizophrenia
Status: Enrolling
Updated: 3/10/2016
CRI Worldwide - Kirkbride
mi
from
Philadelphia, PA
Click here to add this to my saved trials
PEARL Schizophrenia Maintenance
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study Of Lurasidone For The Maintenance Treatment Of Subjects With Schizophrenia
Status: Enrolling
Updated:  3/10/2016
Lincoln Research
mi
from
Lincoln, RI
PEARL Schizophrenia Maintenance
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study Of Lurasidone For The Maintenance Treatment Of Subjects With Schizophrenia
Status: Enrolling
Updated: 3/10/2016
Lincoln Research
mi
from
Lincoln, RI
Click here to add this to my saved trials
PEARL Schizophrenia Maintenance
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study Of Lurasidone For The Maintenance Treatment Of Subjects With Schizophrenia
Status: Enrolling
Updated:  3/10/2016
FutureSearch Clinical Trials LP
mi
from
Austin, TX
PEARL Schizophrenia Maintenance
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study Of Lurasidone For The Maintenance Treatment Of Subjects With Schizophrenia
Status: Enrolling
Updated: 3/10/2016
FutureSearch Clinical Trials LP
mi
from
Austin, TX
Click here to add this to my saved trials
PEARL Schizophrenia Maintenance
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study Of Lurasidone For The Maintenance Treatment Of Subjects With Schizophrenia
Status: Enrolling
Updated:  3/10/2016
Community Clinical Research
mi
from
Austin, TX
PEARL Schizophrenia Maintenance
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study Of Lurasidone For The Maintenance Treatment Of Subjects With Schizophrenia
Status: Enrolling
Updated: 3/10/2016
Community Clinical Research
mi
from
Austin, TX
Click here to add this to my saved trials
PEARL Schizophrenia Maintenance
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study Of Lurasidone For The Maintenance Treatment Of Subjects With Schizophrenia
Status: Enrolling
Updated:  3/10/2016
FutureSearch Clinical Trials, LP
mi
from
Dallas, TX
PEARL Schizophrenia Maintenance
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study Of Lurasidone For The Maintenance Treatment Of Subjects With Schizophrenia
Status: Enrolling
Updated: 3/10/2016
FutureSearch Clinical Trials, LP
mi
from
Dallas, TX
Click here to add this to my saved trials